Navigation Links
Codexis Opens Singapore Laboratory
Date:10/24/2007

SINGAPORE, Oct. 24 /PRNewswire/ -- Codexis, Inc., a private biotechnology company and leading developer of clean manufacturing processes, today announced the opening of Codexis Laboratories Singapore Pte. Ltd. (CLS). CLS is the company's first research facility in Asia, and is an expansion of the company's research and development operations in the U.S. and Europe. CLS will support the company's pharmaceuticals business in both the innovator and generics markets.

The Guest of Honor at the laboratory opening ceremony was Mr. S. Iswaran, Minister of State for Trade and Industry. Other guests included Chu Swee Yeok, Bio*One Chief Executive Officer, Alan Shaw, Ph.D., Codexis President and Chief Executive Officer, Thomas Baruch, Chairman of the Board and other members of the company's Board of Directors. Bio*One Capital led the Codexis Series D private financing round in August 2006.

"Our expansion to Singapore is a significant part of our global development strategy," Dr. Shaw said. "Singapore offers us access to a highly skilled workforce, proximity to our growing customer base in Asia, and a productive business environment as our company grows. Codexis Laboratories Singapore will play an important role in the development of new products serving our pharmaceuticals markets worldwide."

"We are pleased that Codexis, one of the top biocatalyst companies in the world, has chosen to set up its research facility in Singapore," said Mr. S. Iswaran. "This investment is indeed a strong endorsement for our ability to host such cutting-edge R&D activities, and will, no doubt, contribute to ensuring the long-term sustainability of our pharmaceuticals manufacturing sector."

"Bio*One is delighted to welcome Codexis to Singapore," said Ms. Swee-Yeok Chu. "Our investment in Codexis reflects Bio*One's strong support for innovative biomedical sciences companies with cutting-edge technology that will significantly impact the growth of the biomedical industr
'/>"/>

SOURCE Codexis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. NanoRite Innovation Center opens with small science, big promise
2. TomoTherapy opens technical training center
3. Japanese telecom opens liason office at UW-Platteville
4. Test center for RFID capabilities opens next week
5. Eau Claire business-plan contest opens
6. GE Healthcare opens facility meant for 2,000 employees
7. Space Place opens new astronomy center
8. Research on fruit flies opens up possibilities for human treatments
9. Paper technology transfer center opens in Green Bay
10. Nanotech exhibit opens at UW-Madison
11. Doyles Japan trip opens doors and minds for Wisconsin

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...A, Neb., Nov. 5 Transgen...ced financial results for the quarter ended Septem...presented in the tables that follow. ,, Third ...s of $366,000 or $0.01 per share for the third qua... or $0.01 per share for the third quarter of 2008....
(Date:11/5/2009)...DIEGO, CA, November 5, 2009 /PRNewswire-FirstCall/...sed on using proprietary taste receptor-based tech...the food, beverage, and ingredient supply industri... financial results for the third quarter ended Sep...he third quarter of 2009, compared to $4.0 million...
(Date:11/5/2009)... Drug safety specialty firm BioSote... and Informatics earned the Certified Professional...ial from the American Society for Training and Dev... Flewell has more than fifteen years of medical co...nd is responsible for the development of the compa...
(Date:11/4/2009)... The Human Anthrax Vaccine Program ...pleted the feature film "A Call to Arms:2009 ...ary "Fatal Immunity: The Human Anthrax Vaccin... and present danger of top secret government scien...ith no accountability to its victims. It is avail...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7
... and Tragara Pharmaceuticals Inc. today announced ...se to Tragara to develop and commercialize its nov...terms of the agreement S*BIO is eligible to receiv...s an upfront fee, development and sales milestone ...onally, S*BIO will perform certain preclinical act...
... (Nasdaq: NLTX ), today announced that it will f...ic peptide franchise, including CD-NP which is in ...CU-NP which is a pre-clinical compound. Nile will ...urn license rights for the compound to Dr. Cesare ... unable to continue to pursue the development of 2...
...ex: DDD ) today announced that the U. S. Food an...Response letter for its Abbreviated New Drug Appli...n, filed by SCOLR on August 5, 2008, seeks approva...t based on its patented Controlled Delivery Techno...e letter requests additional information, all of w...
Other Biology Technology:S*BIO and Tragara Announce an Exclusive Worldwide License Agreement for Novel Multi-kinase Inhibitor SB1317 2S*BIO and Tragara Announce an Exclusive Worldwide License Agreement for Novel Multi-kinase Inhibitor SB1317 3Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program 2Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program 3Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program 4FDA Issues Complete Response Letter to SCOLR Pharma's Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine 2FDA Issues Complete Response Letter to SCOLR Pharma's Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine 3
(Date:11/6/2009)...h anniversary this month of the publication of On ...iological Sciences (AIBS) is publishing open acces...and his historic insights into evolution. , The t...of California, Berkeley, and James T. Costa of Wes...yths About Charles Darwin," appeared in the Octobe...
(Date:11/5/2009)...ion of Biology Teachers (NABT) will recognize Leon... at Naugatuck Valley Community College (NVCC) in W...cation Award during the NABT annual professional d...09 in Denver, Colorado. , The Evolution Educatio...f Biological Sciences,(AIBS) and Biological Scien...
(Date:11/4/2009)...n natural science) , United States Using Less ... today than it did 35 years ago, despite a 30 perc... partly attributable to alternative cooling method...stems. According to the latest USGS water use repo...ates goes to cooling thermoelectric power plants. ...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Cardiac stem cell trial seeks to treat some heart attack patients 58592 1Cardiac stem cell trial seeks to treat some heart attack patients 58592 2Cardiac stem cell trial seeks to treat some heart attack patients 58592 3Study explores how life experiences contribute to the biological changes of Alzheimers 10197 1Study explores how life experiences contribute to the biological changes of Alzheimers 10197 2Study explores how life experiences contribute to the biological changes of Alzheimers 10197 3FDA Approves PRE PEN Penicillin Allergy Test 58590 1FDA Approves PRE PEN Penicillin Allergy Test 58590 2
...ctedly from the ocean to rescue a dying coral reef...dramatic flair of comic-book superhero Batman, a b...d to death by seaweed ?although the fish was never...s at the ARC Centre of Excellence for Coral Reef S...are lost to weed were astonished when, after remov...
...tic increase in testicular cancer, now the most co...asian men, is the focus of a five-year, $5.5 milli...ublic Health researcher Tongzhang Zheng. , Testicu...his study will provide important information on po...rs,?said Zheng, professor and head of the Division...
...any of them had narrow, pointed teeth, which were ...ing them. But how did they then grind their food? ...they were helped by stones which they swallowed. I...d of ,gastric mill,. But this assumption does not ...ies of Bonn and Tübingen have now proved. Their re...
Other Biology News:Batfish to the rescue! 2Dinosaurs -- stones did not help with digestion 2Dinosaurs -- stones did not help with digestion 3
Custom siRNA, HPLC purified, annealed from Ambion
Silencer Pre-designed siRNA, standard purity from Ambion
Silencer Pre-designed siRNA, standard purity, annealed from Ambion
Silencer Pre-designed siRNA, HPLC purified, annealed from Ambion
Biology Products: